Login
Register
Reset Password
Publish & Distribute
Publishing Solutions
Distribution Solutions
Subjects
Architecture and Design
Arts
Business and Economics
Chemistry
Classical and Ancient Near Eastern Studies
Computer Sciences
Cultural Studies
Engineering
General Interest
Geosciences
History
Industrial Chemistry
Jewish Studies
Law
Library and Information Science, Book Studies
Life Sciences
Linguistics and Semiotics
Literary Studies
Materials Sciences
Mathematics
Medicine
Music
Pharmacy
Philosophy
Physics
Social Sciences
Sports and Recreation
Theology and Religion
Publications
Journals
Books
Proceedings
Publishers
Blog
Contact
Search
EUR
USD
GBP
English
English
Deutsch
Polski
Español
Français
Italiano
Cart
Home
Journals
Journal of Veterinary Research
Volume 63 (2019): Issue 4 (December 2019)
Open Access
Evaluation of long-term antibody response and cross-serotype reaction in ducks immunised with recombinant
Riemerella anatipestifer
outer membrane protein A and CpG ODN
May Phonvisay
May Phonvisay
,
Jai-Wei Lee
Jai-Wei Lee
,
Jhong-Jie Liou
Jhong-Jie Liou
,
Hsian-Yu Wang
Hsian-Yu Wang
and
Chun-Yen Chu
Chun-Yen Chu
| Nov 16, 2019
Journal of Veterinary Research
Volume 63 (2019): Issue 4 (December 2019)
About this article
Previous Article
Next Article
Abstract
Article
Figures & Tables
References
Authors
Articles in this Issue
Preview
PDF
Cite
Share
Published Online:
Nov 16, 2019
Page range:
543 - 548
Received:
Apr 10, 2019
Accepted:
Oct 24, 2019
DOI:
https://doi.org/10.2478/jvetres-2019-0066
Keywords
duck
,
vaccine
,
adjuvant
,
long-term antibody
© 2019 M. Phonvisay et al. published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Fig. 1
Expression and immunogenicity analysis of recombinant OmpA. A – rOmpA separated on 10% SDS-PAGE for protein quantitation. Lanes 1–5 – BSA standards, lane 6 – lysate of E. coli expressing rOmpA induced for 4 h, lane 7 – lysate of E. coli expressing inactivated rOmpA, and lane M – gene marker. B – The 65 kDa of expressed rOmpA separated on 10% SDS-PAGE. Lane 1 – pET-32a incubated for 0 h, lane 2 – pET-32a incubated for 4 h, lane 3 – lysate of E. coli expressing rOmpA induced for 0 h, lane 4 – lysate of E. coli expressing rOmpA induced for 4 h, and lane M – gene marker. C – Western blot analysis with anti-RA duck sera. Lane 1 – pET-32a incubated for 0 h, lane 2 – pET-32a incubated for 4 h, lane 3 – lysate of E. coli expressing rOmpA induced for 0 h, lane 4 – lysate of E. coli expressing rOmpA induced for 4 h and M – gene marker
Fig. 2
RA-specific antibody level in immunised ducks. Different superscript letters indicate statistically significant difference (p < 0.05) between groups for each sampling time point
Fig. 3
Cytokine mRNA levels in immunised ducks. The mRNA expression levels of IFN-α (A), IFN-γ (B), IL-6 (C), and IL-12 (D) are shown as fold change relative to the saline control. Data are presented as the mean ± standard deviation of ducks in the treatment (n = 5). Different superscript letters indicate statistically significant difference (p < 0.05) between groups for the same sampling time point
Fig. 4
Cross-serotype detection by antiserum from ducks immunised with rOmpA + CpG. A – Detection with antiserum of unimmunised ducks. B – Detection with antiserum of ducks immunised with rOmpA + CpG. RA1 – RA serotype 1, RA2 – RA serotype 2, RA6 – RA serotype 6, RA56a – RA of unknown serotype, rOmpA – rOmpA induced for 4 h, and M – protein ladder with labelled molecular weights. The positions of the 65-kDa rOmpA and the 42-kDa OmpA proteins are indicated by the arrows